Register (On-Demand) • Schedule

Role of Cannabis and Cannabidiol in the Treatment of Anxiety Disorders

Registration Options

Activity Dates: 04/07/2024 - 04/07/2027

Sign in (or create a FREE account) to register or access your existing registrations

Session Time and Location

The live session is complete.

Target Audience

If you are a pharmacist, nurse practitioner, or other health care professional involved in the comprehensive medication management of individuals living with mental health and/or substance use disorders, we invite you to participate in this online course.

Session Summary

Limitations with prescription pharmacologic treatments for anxiety disorders can lead to patients seeking alternative treatments, such as cannabis or cannabidiol. Cannabis and cannabidiol are now legal in many states, making them easily accessible to patients. These products are not incorporated into treatment guidelines, leaving clinicians without clear guidance on their role. Study results on the safety and efficacy of cannabis and/or cannabidiol are mixed, making application to patients especially difficult. This session will focus on interpretation of the cannabis/cannabidiol literature so psychiatric pharmacists can determine its application to patients with anxiety disorders. In addition, the presentation will highlight the safety and efficacy of these products so psychiatric pharmacists can properly educate patients and decide if there is a role for their use in the treatment of anxiety.

Consider making this session part of your BPS Continuing Professional Development plan! Please refer to the BPS Psychiatric Pharmacy Content Outline to see how this activity may align.

Course Requirements

To receive ACPE credit for this session, you must:

  • Sign in (or create a FREE account).
  • Register for this course.
  • Review the full content of the activity and reflect upon its teachings.
  • Complete the post-test at the end of the activity no later than the closing activity date.
  • Complete the evaluation at the end of the activity.
  • If necessary, complete the post-test retest no later than the closing activity date.
  • Receive a passing grade (70%).
  • Provide the necessary details in your profile to ensure correct reporting by AAPP to CPE Monitor.

Upon successful completion, ACPE credit is reported within 24 hours to CPE Monitor although transcripts can be retrieved by participants online in their ACPE Transcript.

Faculty Information

Tiffany R Buckley, PharmD, BCPS, BCPP

View biographical information

Learning Objectives

  1. Distinguish between cannabis, hemp, FDA-approved cannabinoids, and synthetic cannabinoids.
  2. Evaluate the role of cannabis and/or cannabidiol in the treatment of anxiety disorders.
  3. Assess the safety of cannabis and/or cannabidiol when used for the treatment of anxiety disorders.

Continuing Education Credit and Disclosures

Activity Dates: 04/07/2024 - 04/07/2027
ACPE Contact Hours: 1
ACPE Number: 0284-0000-24-016-H01-P (Application)
Nursing Credit Reminder: Note that ACPE credit is accepted for ANCC Certification Renewal and AANPCB advanced practice provider content. For specific questions related to your organization's acceptance of ACPE continuing education units, please contact your organization directly.

ACPEThe American Association of Psychiatric Pharmacists is accredited by the Accreditation Council for Pharmacy Education as a provider of continuing pharmacy education.

View AAPP's Privacy Policy

AAPP owns the copyright, is licensed or has received permissions for use of, or is otherwise permitted to use copyrighted materials within any CPE activity. Authors and speakers are required to obtain necessary copyright permissions for content in CPE activities. AAPP complies with copyright laws and regulations.

Questions? Contact AAPP.